G007-LK
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


G007-LK
Description:
G007-LK is a potent and selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
PARPType:
Reference compoundRelated Pathways:
Cell Cycle/DNA Damage; EpigeneticsApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/G007-LK.htmlConcentration:
10mMPurity:
99.24Solubility:
DMSO : ≥ 30 mg/mLSmiles:
ClC1=C (C=CC=C1) N2C (/C=C/C3=NN=C (C4=CC=C (C#N) C=C4) O3) =NN=C2C5=CC=C (S (C) (=O) =O) C=N5Molecular Formula:
C25H16ClN7O3SMolecular Weight:
529.96Precautions:
H302, H315, H319, H335References & Citations:
[1]Voronkov A, et al. Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor. J Med Chem. 2013 Apr 11;56 (7) :3012-23.|[2]Norum JH, et al. The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology. Biol Res. 2018 Jan 9;51 (1) :3.|[3]Xin Chen, et al. Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade. PLoS One. 2017 Sep 6;12 (9) :e0184068.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
TNKS1/PARP5A; TNKS2/PARP5BCAS Number:
1380672-07-0
